This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| AVEVA GROUP PLC | 2,511.0 | 12.6% |
| MELROSE INDUSTRIES PLC | 155.7 | 9.5% |
| SCOTTISH MORTGAGE INV TR PLC | 810.8 | 4.4% |
| OCADO GROUP PLC | 946.6 | 2.8% |
| JD SPORTS FASHION PLC | 121.4 | 2.5% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| AIRTEL AFRICA PLC | 144.7 | -7.6% |
| ROYAL MAIL PLC | 291.0 | -5.3% |
| SCHRODERS PLC | 2828.0 | -2.9% |
| ABRDN PLC | 186.1 | -2.7% |
| RENTOKIL INITIAL PLC | 496.2 | -2.3% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,577 | -0.3% | 6.9% |
| DOW JONES INDUS. AVG | 33,117 | -0.2% | -4.3% |
| DAX INDEX | 14,414 | -1.0% | -7.6% |
| NIKKEI 225 | 28,234 | 1.0% | -2.2% |
| S&P/ASX 200 INDEX | 7,121 | 0.4% | -2.1% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 120.58 | 0.98% |
| Brent Crude (ICE) | USD/bbl. | 121.90 | 1.10% |
| Gold Spot | USD/t oz. | 1,858 | 0.3% |
| Copper (Comex) | USd/lb. | 444 | 0.0% |
The UK 100 is called to open -40 points this morning at 7554. The UK 100 looks set to open in the red today as inflation looks to be top of the agenda again. Attention today will be centred on the ECB, with the talk this week about the possibility of its first rate hike in 11 years after eurozone inflation hit a record 8.1% last month. Oil prices continue to make headlines also. The price of crude rose to almost $124 a barrel overnight with the UAE Oil Minister the latest to warn that high prices are here to stay. This follows on from a tough session overnight in the states which saw the Dow Jones Industrial Average dipped 269.24 points, or 0.81%, to 32,910.90, while the S&P 500 shed 1.08% to close at 4,115.77. The Nasdaq Composite slid 0.73% to finish at 12,086.27.
AO World has decided to close their German business following a strategic review. Their German business represent 10% of their total revenue and the closure will cost up to £15m in cash.
AstraZeneca says Calquence with obinutuzumab shows longer-term survival of leukaemia.
British American Tobacco stuck to its 2022 revenue and earnings forecast, as they state that annual global tobacco industry volume fell 3% due to the uncertainty over the Ukraine-Russia conflict. They are still working towards transferring their Russian business, but they are confident of delivering their financial targets irrespective of how long it takes to offload the unit.
First Group says I Squared takeover offer undervalues the company; board rejects the proposal.
Mitie swings to a FY22 pretax profit o £52.3m, up from a £13.7m loss YoY. They have agreed to acquire Custom Solar for up to £12.4m.
Peel Hunt report a FY pretax profit of £33.1m down 57% YoY from £77m.
Tate & Lyle FY pretax profit falls 54% to £42m, down from £90m YoY. They have completed the acquisition of a dietary fibre business in China. They recommend a final dividend of 12.8p.
HSBC Downgrades Compass Group to Hold from Buy (9 Buys / 11 Holds / 0 Sells)
Kepler Cheuvreux Upgrades Informa to Buy from Hold (7 Buys / 4 Holds / 0 Sells)
Morgan Stanley Upgrades Britvic to Overweight from Equal weight (8 Buys / 8 Holds / 0 Sells)
Mitie Group
Peel Hunt Ltd
Tate & Lyle plc
British American Tobacco
None
Chinese Trade Balance
ECB Interest Rate Decision
ECB Deposit Rate Decision
ECB Monetary Policy Decision Statement
US Initial Jobless Claims
ECB Press Conference
FTSE 100:
Sainsbury (J)
WPP
Associated British Foods
Compass Group
FTSE 250:
Ferrexpo
Johnson Matthey
Computacenter
Marshalls
Assura
IntegraFin Holdings
LondonMetric Property
AJ Bell
Capital Gearing Trust
Temple Bar Investment Trust
Shaftesbury
Worldwide Healthcare Trust
Capital & Counties Properties
BMO Commercial Property Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.